pargyline has been researched along with 1-methyl-4-phenyl-2,3-dihydropyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weight, FF; Wilson, JA; Wilson, JS | 1 |
| Castagnoli, N; Di Monte, D; Ekström, G; Shinka, T; Smith, MT; Trevor, AJ | 1 |
2 other study(ies) available for pargyline and 1-methyl-4-phenyl-2,3-dihydropyridinium
| Article | Year |
|---|---|
MPDP+ causes a non-reversible decrease in neostriatal synaptic transmission in mouse brain slice.
Topics: Animals; Corpus Striatum; In Vitro Techniques; Mice; Pargyline; Pyridinium Compounds; Synapses; Synaptic Transmission | 1987 |
Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Biotransformation; Dose-Response Relationship, Drug; Ions; Liver; Male; Pargyline; Pyridines; Pyridinium Compounds; Rats | 1987 |